ICU Map
renal

Severe Hyperkalemia & Cardiac Membrane Instability

Time-critical hyperkalemia protocol (K+ > 6.5 mEq/L or ECG changes): immediate membrane stabilization with IV Calcium, intracellular shifting with Insulin/Dextrose and beta-agonists, and definitive potassium elimination.

Severe hyperkalemia (serum potassium [K+] > 6.5 mEq/L, or any potassium elevation accompanied by ECG changes or muscle weakness) is a time-critical cardiovascular emergency. Elevated extracellular potassium partially depolarizes the resting membrane potential of cardiomyocytes, inactivating voltage-gated sodium channels and slowing cardiac conduction velocity, leading swiftly to ventricular fibrillation, high-grade AV block, sine wave rhythm, and asystolic cardiac arrest.

Caution

Dangerous Diagnosis Not to Miss: Imminent Hyperkalemic Cardiac Arrest (sine wave ECG progressing to VF/asystole), Severe Acute Rhabdomyolysis (massive muscle breakdown releasing intracellular potassium and myoglobin), Tumor Lysis Syndrome, and Anuric Acute Renal Failure.

CLINICAL ALGORITHMMedically Verified (2026-09-16)

Severe hyperkalemia: stabilize, shift, remove

Figure: Severe hyperkalemia: stabilize, shift, remove. This action-focused visual summarizes the linked Clinical Problem; the full problem text, evidence references and local policy remain the source of truth.(Action pathway — use the full evidence-linked problem and local protocol for clinical decisions)
1

RECOGNIZE ECG SIGNS OF HYPERKALEMIA

  • Progression of electrophysiologic signs (can occur unpredictably or rapidly):

  • K+ 5.5–6.5 mEq/L: Tall, peaked, symmetrical T-waves with a narrow base (best seen in precordial leads V2–V4).

  • K+ 6.5–7.5 mEq/L: PR interval prolongation, loss/flattening of P-waves, ST-segment depression.

  • K+ 7.5–8.5 mEq/L: QRS complex widening, bundle branch blocks, fascicular blocks, high-grade AV block, junctional or ventricular bradycardia.

  • K+ > 8.5 mEq/L: Merging of wide QRS with T-wave forming the ominous 'Sine Wave' pattern -> immediate Ventricular Fibrillation or Asystole.

2

PILLAR 1: IMMEDIATE CARDIAC MEMBRANE STABILIZATION (0 TO 5 MINUTES)

  • Indication: Any ECG changes (peaked T-waves, wide QRS, loss of P) OR serum K+ > 6.5–7.0 mEq/L.

  • Mechanism: Calcium restores resting membrane threshold potential, counteracting potassium depolarization without lowering serum potassium.

  • Dosing & Administration:

    • IV Calcium Gluconate (10%): 30 mL (3 grams / 3 ampules) IV over 5–10 minutes (preferred for peripheral IV access; lower tissue necrosis risk).
    • IV Calcium Chloride (10%): 10 mL (1 gram / 1 ampule) IV over 2–5 minutes via central line (or during active cardiac arrest / peri-arrest; provides 3x more elemental calcium).
    • Onset & Duration: Onset in 1–3 minutes; duration 30–60 minutes. Repeat bolus in 5–10 minutes if ECG abnormalities persist.
3

PILLAR 2: INTRACELLULAR POTASSIUM SHIFTING (5 TO 15 MINUTES)

  • Drives extracellular potassium into cells temporarily (buys 2–4 hours for elimination):

  • IV Regular Insulin + Dextrose (Gold Standard):

    • Administer Regular Insulin 10 Units IV bolus + 50 mL of D50W (25 g Dextrose) IV push over 5 minutes.
    • In patients with baseline blood glucose < 150 mg/dL or renal failure: Give 5 Units Regular Insulin + 50 mL D50W, followed by continuous D10W infusion (50–100 mL/hr for 4–6h) to prevent delayed, life-threatening hypoglycemia.
    • Lowers serum K+ by 0.6 to 1.0 mEq/L within 15–30 minutes.
  • Inhaled Beta-2 Agonists (Albuterol):

    • Nebulize Albuterol 10 to 20 mg in 4 mL saline continuously over 15 minutes (stimulates Na+/K+ ATPase via beta-2 receptor cAMP).
    • Lowers K+ by 0.5–1.0 mEq/L; synergistic with insulin (use cautiously in active myocardial ischemia or severe tachyarrhythmias).
  • IV Sodium Bicarbonate (8.4%):

    • 50–100 mEq IV infusion over 15–30 minutes; effective ONLY in patients with severe concurrent metabolic acidemia (pH < 7.20); minimal efficacy in normal pH.
4

PILLAR 3: DEFINITIVE POTASSIUM ELIMINATION

5

REASSESSMENT & HYPOGLYCEMIA MONITORING

Caution

Common Diagnostic Trap: Giving shifting agents (Insulin/Dextrose and Albuterol) and assuming the hyperkalemia is resolved. Shifting agents wear off in 2 to 4 hours, causing intracellular potassium to leak back into the extracellular space with rebound fatal arrhythmias unless definitive elimination (diuresis, binders, or dialysis) was initiated simultaneously.

Destination Topics

  • Hyperkalemia: Comprehensive membrane biophysics, EKG gallery, and dialytic removal.

  • AKI: Acute tubular necrosis and renal electrolyte management.

  • CRRT: Continuous venovenous hemodiafiltration and dialysate potassium prescription.

  • Arrhythmias: Conduction blocks, sine wave rhythms, and overdrive pacing.

  • Cardiac Arrest: ACLS arrest algorithms for hyperkalemia and toxic ingestions.

Evidence status

Review metadata not yet recorded.

Status, review dates and guideline versions appear here once editorial metadata is authored for this content.